Antibody Drug Discovery: From Target Validation to Candidate Selection

This webinar will provide an overview of the antibody discovery process highlighting the critical steps involved in developing effective antibody-based therapeutics. The goal is to guide the audience through the different stages of antibody drug discovery, shedding light on the latest advancements, methodologies and challenges encountered along the way. In addition, the webinar will cover Benchling’s Antibody Solution Accelerator, a set of ready-to-use configurations necessary to capture the process of drug discovery.

Throughout the webinar, attendees will gain valuable insights into how Benchling’s Antibody Solution Accelerator supports the critical elements of antibody discovery, ensuring a more streamlined and successful drug development process. Register now to learn best practices for target identification, screening, lead selection and in vivo safety and efficacy.

Speakers

Vega Shah, PhD, Senior Product Marketing Manager, Benchling

Vega Shah is an experienced biologist and former research scientist. In her current role, she helps biotech companies use software to accelerate their research. She was previously a product manager for an electronic lab notebook for biologics and screening. Prior to her industry career, she was a scientific researcher at Lawrence Berkeley National Lab, University of Washington and UC Berkeley.

Message Presenter

Sanjay Saraf, Product Manager, Benchling

Sanjay Saraf is a Product Manager at Benchling, where he helps biotech companies solve data analysis, automation, and preclinical research problems. He is now focused on Studies, a product which enables scientists to capture accurate, intelligent and connected in vivo study data. Prior to Benchling, Sanjay led healthcare and biology partnerships at Palantir Technologies, focusing on pharma, government and clinical organizations.

Message Presenter